Literature DB >> 25794920

Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.

Seiji Asai1, Tetsuya Fukumoto2, Nozomu Tanji3, Noriyoshi Miura4, Masao Miyagawa5, Kenichi Nishimura6, Yutaka Yanagihara7, Akitomi Shirato8, Yuki Miyauchi9, Tadahiko Kikugawa10, Masayoshi Yokoyama11.   

Abstract

BACKGROUND: The purpose of this study was to assess the ability of fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to detect upper urinary tract urothelial carcinomas (UTUC) compared with pathological examination of tissues obtained by ureteroscopic biopsy and split cytologic analysis of urine obtained after retrograde pyelography.
METHODS: Clinicopathological records of patients at our institution were retrospectively reviewed. Fifty patients with clinically suspected UTUC, who were histologically diagnosed by nephroureterectomy, partial ureterectomy, or endoscopic biopsy, were included. The patient cohort included 42 men and 8 women, with a median age of 73 (range 54-92) years.
RESULTS: Only 27 % of 49 patients with UTUC had positive voided urine cytology, and 33 % of 40 patients had positive split urine cytology. In addition, 40 % of 10 patients had a positive endoscopic biopsy. However, 83 % of 48 patients with UTUC had positive results from FDG-PET/CT examination. The positive predictive value of FDG-PET/CT was 95 %. There were no correlations between sensitivity and tumor stage or tumor grade. Sensitivity of FDG-PET/CT for patients with and without diabetes mellitus was 60 and 89 %, respectively.
CONCLUSIONS: These preliminary results from a small number of patients revealed that FDG-PET/CT enabled effective detection of UTUC.

Entities:  

Keywords:  FDG-PET/CT; Upper urinary tract urothelial carcinoma; Ureteroscopy; Urine cytology

Mesh:

Substances:

Year:  2015        PMID: 25794920     DOI: 10.1007/s10147-015-0817-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  18 in total

1.  Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.

Authors:  Jamie Messer; Shahrokh F Shariat; James C Brien; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Robert G Uzzo; Mark Wille; Scott E Eggener; Gary Steinberg; John D Terrell; Steven M Lucas; Yair Lotan; Stephen A Boorjian; Jay D Raman
Journal:  BJU Int       Date:  2011-02-14       Impact factor: 5.588

2.  Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract.

Authors:  S A Potts; P A Thomas; M B Cohen; S S Raab
Journal:  Mod Pathol       Date:  1997-07       Impact factor: 7.842

3.  Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.

Authors:  Koichi Koyama; Terue Okamura; Joji Kawabe; Nozomi Ozawa; Kenzi Torii; Naohiko Umesaki; Masato Miyama; Hironobu Ochi; Ryusaku Yamada
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

4.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

5.  Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer.

Authors:  S Kosuda; P V Kison; R Greenough; H B Grossman; R L Wahl
Journal:  Eur J Nucl Med       Date:  1997-06

6.  Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma.

Authors:  Akira Takao; Takashi Saika; Shinya Uehara; Koichi Monden; Fernando Abarzua; Yasutomo Nasu; Hiromi Kumon
Journal:  Jpn J Clin Oncol       Date:  2010-06-24       Impact factor: 3.019

7.  Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging?

Authors:  Tadashi Hara; Tatsuya Higashi; Yuji Nakamoto; Tsuyoshi Suga; Tsuneo Saga; Takayoshi Ishimori; Koichi Ishizu; Hidekazu Kawashima; Shigeto Kawase; Keiichi Matsumoto; Kaori Togashi
Journal:  Ann Nucl Med       Date:  2009-08-07       Impact factor: 2.668

8.  Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.

Authors:  Karen A Büsing; Stefan O Schönberg; Joachim Brade; Klaus Wasser
Journal:  Nucl Med Biol       Date:  2012-12-08       Impact factor: 2.408

9.  Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls.

Authors:  Fabio Tavora; Daniel A Fajardo; Thomas K Lee; Tamara Lotan; Jeremy S Miller; Hiroshi Miyamoto; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

10.  Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

Authors:  P Lindholm; H Minn; S Leskinen-Kallio; J Bergman; U Ruotsalainen; H Joensuu
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

View more
  6 in total

1.  Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma.

Authors:  Fabio Zattoni; Laura Evangelista; Andrea Guttilla; Filiberto Zattoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-02       Impact factor: 9.236

Review 2.  PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Authors:  Ahmed Ebada Salem; Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 3.  Update on advances in molecular PET in urological oncology.

Authors:  Kazuhiro Kitajima; Shingo Yamamoto; Kazuhito Fukushima; Ryogo Minamimoto; Takao Kamai; Hossein Jadvar
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

4.  18F-FDG PET/CT images defined the true extent of a urothelial bladder carcinoma.

Authors:  L S Almeida; A O Santos; G H Martins; L Eloy; M L Lima; E Etchebehere
Journal:  Urol Case Rep       Date:  2020-05-28

5.  Role of 18F-FDG-PET/CT in Combination With Neutrophil-Lymphocyte Ratio in the Diagnosis of Upper Urinary Tract Lesion: Can We Accurately Predict Malignant Tumor?

Authors:  Zhi-Bin Ke; Xiao-Dan Lin; Ye-Hui Chen; Yun-Zhi Lin; Shao-Hao Chen; Shao-Ming Chen; Yu Chen; Yong Wei; Qing-Shui Zheng; Xue-Yi Xue; Xiao-Dong Li; Ning Xu
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

Review 6.  PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.

Authors:  Abdul Razik; Chandan Jyoti Das; Sanjay Sharma
Journal:  Indian J Urol       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.